Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

NCT02764593

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Florida Cancer Center at Orlando Health Orlando, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Louisville Louisville, Kentucky, United States
View Trial Details
Completed

DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

NCT03237325

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +11 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Loma Linda University Health Loma Linda, California, United States
  • Pomona Valley Hospital Medical Center Pomona, California, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
View all 53 locations
View Trial Details
Completed

Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma

NCT03502148

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Advanced ENT and Allergy Louisville, Kentucky, United States
  • University of Cincinnati Cancer Institute Cincinnati, Ohio, United States
  • Ben Taub Hospital Houston, Texas, United States
  • Memorial Hermann Hospital Houston, Texas, United States
View Trial Details
Completed

Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)

NCT02105636

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Local Institution - 0001 Atlanta, Georgia, United States
  • Local Institution - 0002 Chicago, Illinois, United States
View all 64 locations
View Trial Details
Completed

Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT01458392

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Acceleron Investigative Site Aurora, Colorado, United States
  • Acceleron Investigative Site Atlanta, Georgia, United States
  • Acceleron Investigative Site Boston, Massachusetts, United States
  • Acceleron Investigative Site Detroit, Michigan, United States
View Trial Details
Completed

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

NCT03241173

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +74 more
Locations
  • The University of Alabama Birmingham (UAB) Birmingham, Alabama, United States
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
View all 15 locations
View Trial Details

Related conditions